SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Barnwell Industries entered into a definitive Purchase and Sale Agreement on July 31, 2026, to sell its remaining Hawaii development interests, including partnership interests in KKM Makai, LLLP and KD Kona 2013 LLLP, plus related project rights, for approximately $1.5 million in net cash proceeds. This material disposition represents a strategic exit from the Company's Hawaii real-estate interests and portfolio simplification.
View raw filing on EDGAR →This Item 3.02 discloses the issuance of 34,376,167 shares of common stock to the Company's Chairman upon conversion of $105.8 million in convertible promissory notes. Although technically exempt from registration under Section 3(a)(9) as an exchange with an existing security holder, this represents a substantial dilutive equity issuance that materially increases share count (from ~66.5M to ~100.8M shares, a 52% increase) and significantly increases the Chairman's ownership stake to 44.3% of voting power. The conversion eliminates substantial debt but creates substantial dilution to existing shareholders.
View raw filing on EDGAR →This is a clear earnings release disclosing Neutron Holdings' (Lime) financial results for Q2 2026 ended June 30, 2026. The filing explicitly states "On August 4, 2026, Neutron Holdings, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2026" and includes the full press release as Exhibit 99.1 with consolidated financial statements (balance sheet, income statement, cash flows), revenue of $304 million (up 24% YoY), net income of $295 million, and forward guidance for Q3 and full year 2026. This is a material disclosure affecting investor assessment of the registrant's financial performance.
View raw filing on EDGAR →Select Water Solutions issued a press release on August 4, 2026, announcing its financial results for the second quarter ended June 30, 2026, disclosing consolidated revenue of $396 million, net income of $22.6 million, and Adjusted EBITDA of $92.7 million. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the canonical Item for earnings disclosures.
View raw filing on EDGAR →Electronic Arts completed its acquisition by a consortium of PIF, Silver Lake, and Affinity Partners for $210 per share in cash on August 4, 2026. The transaction, previously announced on September 29, 2025 and approved by stockholders on December 22, 2025, resulted in a change of control, with EA becoming a wholly owned subsidiary of the Consortium. EA's common stock ceased trading and was delisted from NASDAQ upon closing.
View raw filing on EDGAR →Seven directors—Kofi Bruce, Rachel A. Gonzalez, Jeffrey T. Huber, Talbott Roche, Richard A. Simonson, Luis Ubiñas, and Heidi Ueberroth—voluntarily resigned from the board and all committees effective at the closing of the acquisition on August 4, 2026.
View raw filing on EDGAR →The 6-K discloses early settlement of an exchange offer whereby Murano Global Investments PLC exchanged outstanding 11.000% Senior Secured Notes due 2031 for new Fixed Rate Senior Secured Notes due 2032, coupled with a concurrent consent solicitation on the existing indenture. This constitutes creation of a new direct financial obligation (the New Notes) and modification of existing debt terms, fitting the debt_issuance category. The exchange and refinancing of material debt instruments is material to investors assessing the registrant's capital structure and financial obligations.
View raw filing on EDGAR →ePlus disclosed its first quarter fiscal 2027 financial results on August 4, 2026, reporting net sales of $649.1 million (up 1.0%), gross profit of $151.3 million (down 1.5%), net earnings from continuing operations of $30.3 million (down 5.4%), and adjusted EBITDA of $47.8 million (down 9.2%), along with segment performance and reaffirmed fiscal 2027 guidance.
View raw filing on EDGAR →ePlus's Board of Directors declared a quarterly cash dividend of $0.27 per common share payable on September 16, 2026, to shareholders of record as of August 25, 2026.
View raw filing on EDGAR →This press release discloses progress on ING's €1.0 billion share buyback programme announced on 30 April 2026. The exhibit reports that 740,000 shares were repurchased during the week of 27 July–31 July 2026 at an average price of €29.58, with cumulative repurchases of 17,765,193 shares at €26.65 average price totaling €473.4 million (47.34% of the programme completed). Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." This is material to investors as it reflects capital allocation policy and affects share count and earnings per share.
View raw filing on EDGAR →The 6-K body discloses Q2 2026 adjusted sales (DKK 78,488 million, +7% at CER) and adjusted operating profit (DKK 33,389 million, +11% at CER), along with a raised full-year 2026 outlook for adjusted sales and operating profit growth (0% to -6% at CER, improved from prior guidance of -4% to -12%). This is a discrete earnings announcement with quarterly results and updated forward guidance, not a periodic financial report. The material impairment charge (DKK 6.3 billion non-recurring impairment on intangible pipeline assets) is disclosed but is secondary to the primary event—the earnings release and outlook revision.
View raw filing on EDGAR →PennantPark Investment Corporation announced its monthly distribution of $0.08 per share for August 2026, comprised of a $0.04 base dividend and $0.04 supplemental dividend, payable on September 1, 2026. This is a clear declaration and announcement of a dividend distribution to shareholders, which is material to investors in a BDC that relies on regular distributions as a key component of shareholder returns.
View raw filing on EDGAR →The filing announces a monthly distribution of $0.0833 per share for August 2026, comprised of an $0.08 base dividend and $0.0033 supplemental dividend, payable on September 1, 2026. This is a routine but material disclosure of a dividend declaration by a regulated investment company (RIC), which is a core shareholder communication for this asset class.
View raw filing on EDGAR →BlackLine issued a press release on August 4, 2026 disclosing second quarter 2026 financial results, including GAAP revenues of $187.8 million (up 9.2% YoY), GAAP net income of $16.5 million ($0.27 per diluted share), and forward guidance for Q3 and full-year 2026. This is a standard quarterly earnings release filed under Item 2.02 and attached as Exhibit 99.1, which is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →Stride, Inc. issued a press release on August 4, 2026 announcing its financial results for the fourth quarter and full fiscal year ended June 30, 2026, disclosing 4.7% revenue growth, 25.2% increase in operating income, and 20.0% increase in diluted EPS.
View raw filing on EDGAR →Stride, Inc. announced an extension of its existing stock repurchase program through October 31, 2027, with $311.3 million remaining availability, continuing its capital allocation strategy following $188.7 million in repurchases during fiscal 2026.
View raw filing on EDGAR →SNDL announced successful completion of an EU-GMP audit at its Atholville cultivation facility, with anticipated certification within 90 days. This is a material operational and regulatory milestone that strengthens the company's ability to participate in international medical cannabis markets. The disclosure emphasizes the facility's strategic importance, scale (380,000 sq ft, ~4,500 kg/quarter capacity), and the company's commitment to quality and regulatory compliance. While not a discrete event type like M&A or impairment, this regulatory achievement materially affects the company's operational capacity and market opportunities.
View raw filing on EDGAR →SLR Investment Corp. issued a press release on August 4, 2026 announcing quarterly financial results for the period ended June 30, 2026, disclosing net investment income of $0.33 per share, net asset value of $18.00 per share, and a declared quarterly distribution of $0.31 per share. This is a standard earnings release for a closed-end investment company, filed under Item 2.02 with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →Hyster-Yale issued a press release on August 4, 2026 announcing unaudited financial results for Q2 2026 and the six-month period ended June 30, 2026. The disclosure includes consolidated revenue, operating profit/loss, net income/loss, and diluted EPS figures, along with detailed segment results and forward-looking guidance. This is a standard quarterly earnings release attached as Exhibit 99, disclosed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →Hyster-Yale disclosed Q1 and Q2 2026 financial results showing significant deterioration: consolidated revenues declined 12.7% and 15.0% year-over-year respectively, with net losses of $30.5M and $31.6M compared to prior-year net income of $8.6M and losses of $13.9M. Operating losses of $28.0M and $18.4M were reported across the two quarters.
View raw filing on EDGAR →Wynn Resorts disclosed second quarter 2026 financial results with operating revenues of $1.86 billion (up from $1.74 billion in Q2 2025), net income of $140.1 million (up from $66.2 million), and diluted EPS of $1.32 (up from $0.64), along with detailed consolidated results and property-level performance metrics.
View raw filing on EDGAR →The 6-K furnishes two discrete announcements: (1) approval of the first tranche of the 2026 dividend (€0.27 per share), and (2) Eni's consolidated results for Q2 and H1 2026, including detailed financial tables, segment performance, and forward guidance. The second announcement is a comprehensive earnings release disclosing quarterly and half-year financial results with proforma adjusted EBIT of €5.38 bln in Q2 (doubling y-o-y), adjusted net profit of €2.3 bln, and raised FY guidance on production growth (now ~5%) and shareholder distributions (€3.4 bln buyback). This is material to investors assessing the registrant's financial performance and capital allocation.
View raw filing on EDGAR →This is a press release announcing Tower Semiconductor's Q2 2026 financial results, including record revenue of $460 million (24% YoY growth), record gross profit of $138 million, record operating profit of $90 million, and record net profit of $91 million. The release also provides Q3 2026 revenue guidance of $520 million (31% YoY growth). This is a classic earnings release disclosing quarterly financial results and forward guidance, material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →This is a press release announcing G. Willi-Food International's unaudited financial results for the second quarter and first half of fiscal year 2026, with detailed income statements, balance sheets, and cash flow statements. The disclosure includes key metrics such as sales (NIS 160.5M for Q2), gross profit (up 21.5% YoY), operating profit (up 22.7% YoY), and net profit (down 33.9% YoY), along with management commentary on operational improvements and the new logistics center. This is a classic earnings release event material to investors assessing the company's financial performance.
View raw filing on EDGAR →The exhibit is a press release announcing that G. Willi-Food's Board of Directors has declared a cash dividend distribution of NIS 20 million (approximately US$6.5 million), or NIS 1.44 per ordinary share (approximately US$0.47 per share), payable to shareholders of record as of August 18, 2026, with payment on September 3, 2026. This is a straightforward dividend declaration that would materially affect investor assessment of capital allocation and shareholder returns.
View raw filing on EDGAR →G. Willi-Food announces its voluntary delisting from NASDAQ and intention to deregister from SEC reporting obligations, concentrating trading solely on the Tel Aviv Stock Exchange. The company states it will file Form 25 on or about August 17, 2026, with the last trading day expected no earlier than August 26, 2026, and Form 15F on or about August 28, 2026. This is a material change in listing status that directly affects where and how shareholders can trade the company's shares and fundamentally alters the regulatory framework governing the company.
View raw filing on EDGAR →Silexion disclosed positive preclinical research findings for its lead candidate SIL204 demonstrating multi-mechanism immune sensitization in KRAS-driven cancers. While this is a research milestone rather than a clinical trial result or earnings release, it represents material operational progress for a clinical-stage biotech company advancing toward Phase 2/3 evaluation. The disclosure emphasizes the scientific rationale for combination therapy and the company's clinical advancement, making it operationally significant to investors assessing the company's pipeline and therapeutic potential.
View raw filing on EDGAR →The 6-K body explicitly states that on August 4, 2026, AudioCodes issued a press release "announcing financial results for the second quarter of 2026, a semi-annual cash dividend, and other matters," with the press release attached as Exhibit 1. This is a discrete earnings announcement for Q2 2026 results, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →VSee Health received a Staff Delisting Determination from Nasdaq on July 30, 2026, indicating that the Company's securities will be delisted from the Nasdaq Capital Market effective August 6, 2026, due to failure to maintain the minimum $1.00 bid price requirement and triggering the $0.10 or less closing bid price rule for ten consecutive trading days. This is a definitive delisting notice, not merely a risk or warning, making it a material event that fundamentally affects the registrant's public market status and investor access to the securities.
View raw filing on EDGAR →Z Squared Inc. entered into a definitive Membership Interest Purchase Agreement on July 31, 2026, to acquire 100% of Paradox Data, LLC for up to $25 million in Series A Convertible Preferred Stock ($5 million at closing plus up to $20 million in milestone payments). The acquisition represents a material strategic expansion of Z Squared's AI infrastructure capabilities, adding up to 150 MW of AI-ready data center capacity.
View raw filing on EDGAR →This is a standard earnings release disclosing IDEAYA's financial results for Q2 2026 (ended June 30, 2026), including collaboration revenue of $8.9 million, R&D expenses of $108.7 million, G&A expenses of $22.5 million, and a net loss of $112.5 million. The filing is furnished under Item 2.02 (Results of Operations and Financial Condition) with the full press release attached as Exhibit 99.1, which is the typical structure for quarterly earnings disclosures. The release also includes material business updates on clinical trial progress and cash position ($1.24 billion), making it material to investors.
View raw filing on EDGAR →Toyota disclosed FY2027 First Quarter Financial Results for the three-month period ending June 30, 2026, reporting consolidated operating income of 1.063 trillion yen, net income of 1.477 trillion yen, and vehicle sales of 2.411 million units, along with revised full-year FY2027 forecasts.
View raw filing on EDGAR →Toyota's Board of Directors resolved on August 4, 2026 to repurchase up to 500 million shares (4.22% of issued shares) for a maximum of JPY 1 trillion and retire 200 million treasury shares, representing a material capital return to shareholders.
View raw filing on EDGAR →Quanta Services entered into an underwriting agreement on August 3, 2026, to issue $2 billion in aggregate principal amount of senior notes across three tranches (4.850% due 2029, 5.300% due 2033, and 5.550% due 2036), with proceeds intended for general corporate purposes including repayment of existing borrowings.
View raw filing on EDGAR →Waters Corporation announced its Q2 2026 financial results on August 4, 2026, with total reported revenue of $1.645 billion, organic revenue growth of 7% as reported and 9% in constant currency, and adjusted EPS of $3.05. The company also raised full-year 2026 guidance across all components, including organic constant currency revenue growth of 7-9% and adjusted EPS of $14.45-$14.65 (10-12% growth). This is a standard quarterly earnings release with press release furnished as Exhibit 99.1, typical of Item 2.02 disclosures.
View raw filing on EDGAR →Trex Company issued a press release on August 4, 2026, announcing financial results for Q2 2026 and six months ended June 30, 2026. The disclosure includes net sales of $418 million, gross margin of 37.9%, net income of $62 million, and diluted EPS of $0.60, along with full-year 2026 guidance reaffirmation and Q3 guidance. This is a standard quarterly earnings release filed under Item 2.02 with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →Vivid Seats issued a press release on August 4, 2026 disclosing second quarter 2026 financial results, including Marketplace GOV of $659.4 million, revenues of $129.9 million, net loss of $14.3 million, and adjusted EBITDA of $12.6 million. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes condensed consolidated financial statements and forward guidance for full-year 2026.
View raw filing on EDGAR →This is a clear earnings release disclosing United Parks & Resorts Inc.'s financial results for Q2 and first six months of fiscal 2026. The filing explicitly states it is "issued a press release announcing the results of the Company's operations for the second quarter ended June 30, 2026" and is furnished under Item 2.02 of Form 8-K. The press release includes detailed financial metrics (total revenue of $483.3M for Q2, net income of $63.3M, Adjusted EBITDA of $195.5M) and operational highlights (6.1M attendance, per-capita spending metrics), which are material to investors assessing the company's operating performance.
View raw filing on EDGAR →ADTRAN announced its unaudited financial results for the second quarter ended June 30, 2026, via press release and investor presentation. The disclosure includes revenue of $281.1 million (up 6.1% year-over-year), GAAP diluted loss per share of $0.13, and forward guidance for Q3 2026 revenue and operating margin.
View raw filing on EDGAR →The filing discloses the expected completion of a merger and internalization transaction on August 6, 2026. ACRES Commercial Realty Corp. will acquire ACRES Capital Corp (its external manager) through a merger, with ACC shareholders receiving 2.61882 shares of ACR common stock per share (7,478,994 shares total), and the Company will become internally managed. This is a material acquisition and change of control event under Item 1.01/2.01 standards, even though disclosed under Item 8.01.
View raw filing on EDGAR →This is a clear earnings release disclosing Pediatrix Medical Group's quarterly financial results for the three and six months ended June 30, 2026. The filing explicitly states in Item 2.02 that the company "issued a press release announcing the results of its operations" and attaches the press release as Exhibit 99.1. The release reports net revenue of $488 million, net income of $40 million, diluted EPS of $0.49, and Adjusted EBITDA of $76 million for Q2 2026, along with six-month results and forward guidance for full-year 2026 Adjusted EBITDA of $280–$300 million. This is material to investors assessing the registrant's financial performance and operational trends.
View raw filing on EDGAR →Kimco Realty issued a press release on August 4, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing net income of $0.22 per diluted share, FFO of $0.46 per diluted share, and raising its 2026 full-year outlook. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings releases.
View raw filing on EDGAR →Bruker Corporation issued a press release on August 4, 2026, announcing financial results for the three and six months ended June 30, 2026. The disclosure includes Q2-26 revenue of $838.5 million (up 5.2% yoy), GAAP diluted loss per share of $(0.41), non-GAAP diluted EPS of $0.49, and updated FY2026 guidance for revenues of $3.54 to $3.57 billion and non-GAAP EPS of $2.10 to $2.15. This is a standard quarterly earnings release with detailed financial results and forward guidance, filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →This is a quarterly earnings release for Q2 2026 (three months ended June 30, 2026) disclosing financial results including research and development expenses ($36.2M), general and administrative expenses ($10.5M), and net loss ($52.8M), along with cash position ($433.1M) and operational updates. The press release is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for results of operations and financial condition disclosures.
View raw filing on EDGAR →Larimar Therapeutics announced its second quarter 2026 financial results and operational highlights on August 4, 2026, disclosing a net loss of $32.8 million for Q2 2026 (versus $26.2 million for Q2 2025), cash position of $156.3 million, detailed expense breakdowns, cash runway projections, and material clinical milestones including initiation of a rolling BLA submission and expected Phase 3 dosing in Q3 2026.
View raw filing on EDGAR →This is a clear earnings release disclosing Beam Therapeutics' second quarter 2026 financial results. The filing explicitly states "On August 4, 2026, the Company issued a press release announcing its financial results for the quarter ended June 30, 2026" and includes condensed consolidated balance sheet and statement of operations data showing net loss of $122.7 million for Q2 2026 versus $102.1 million in Q2 2025, along with cash position, R&D and G&A expenses, and cash runway guidance through mid-2029. This is a material disclosure affecting investor assessment of the registrant's financial condition.
View raw filing on EDGAR →This is IQM Quantum Computers' first earnings release as a public company, disclosing first half and second quarter 2026 financial results (revenue of EUR 8.9 million, operating loss of EUR 60.5 million for H1 2026) along with full-year 2026 guidance (EUR 42–47 million revenue target). The exhibit includes consolidated financial statements (balance sheet, income statement, cash flow statement) and is explicitly titled "Half year financial report" dated August 4, 2026. This is a material event for a newly listed company establishing its public financial track record and forward guidance.
View raw filing on EDGAR →Xometry issued a press release on August 4, 2026 announcing its second quarter 2026 financial results for the period ended June 30, 2026. The disclosure includes consolidated revenue of $229 million (41% YoY growth), gross profit of $87.2 million (34% YoY growth), Adjusted EBITDA of $14.1 million, and forward guidance for Q3 and full-year 2026. This is a standard quarterly earnings release with detailed financial highlights, business metrics, and outlook, furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →Palvella Therapeutics reported second quarter 2026 financial results, including R&D expenses of $12.5M, G&A expenses of $8.9M, a net loss of $21.9M ($1.52 per share), and a cash position of $250.6M as of June 30, 2026, along with operational and clinical development updates.
View raw filing on EDGAR →This is a standard earnings release disclosing quarterly financial results for Q2 2026 (quarter ended June 30, 2026), filed under Item 2.02 as a press release exhibit. The disclosure includes condensed statements of operations, balance sheet data, R&D and G&A expenses, net loss per share, and cash position—all hallmarks of an earnings release. While the filing also mentions operational updates (clinical trial progress, executive appointments, name change), the core Item 2.02 disclosure is the quarterly financial results announcement.
View raw filing on EDGAR →